share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(4.0%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(4.0%)

SC 13G/A:超过5%持股股东披露文件(修正)-JPMORGAN CHASE & CO.(4.0%)
美股sec公告 ·  06/07 12:11
Moomoo AI 已提取核心信息
JPMorgan Chase & Co. has filed an amended Schedule 13G with the United States Securities and Exchange Commission on June 7, 2024, indicating a change in their holdings of Exact Sciences Corporation. The filing reveals that JPMorgan now beneficially owns 7,521,686 shares of Exact Sciences Corporation, which represents 4.0% of the company's class of common stock. This marks a decrease in ownership, as the filing indicates that JPMorgan has ceased to be the beneficial owner of more than five percent of the class of securities. The shares are held across various JPMorgan entities, including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC, among others. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intention of changing or influencing the control of Exact Sciences Corporation.
JPMorgan Chase & Co. has filed an amended Schedule 13G with the United States Securities and Exchange Commission on June 7, 2024, indicating a change in their holdings of Exact Sciences Corporation. The filing reveals that JPMorgan now beneficially owns 7,521,686 shares of Exact Sciences Corporation, which represents 4.0% of the company's class of common stock. This marks a decrease in ownership, as the filing indicates that JPMorgan has ceased to be the beneficial owner of more than five percent of the class of securities. The shares are held across various JPMorgan entities, including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC, among others. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intention of changing or influencing the control of Exact Sciences Corporation.
摩根大通于2024年6月7日向美国证券交易委员会提交了修正后的13G表,表明其精密科学公司股权发生了变化。报告显示,摩根大通现在拥有精密科学公司7521686股普通股,占该公司普通股总数的4.0%。这标志着其持股比例下降,因为报告表明,摩根大通已不再是该证券种类中五成以上的法定所有人。这些股份由各种摩根大通实体持有,包括特拉华州摩根大通信托公司和摩根大通证券有限责任公司等。报告声称这些股份是以业务常规方式获得并持有的,而非意图改变或影响精密科学公司的控制权。
摩根大通于2024年6月7日向美国证券交易委员会提交了修正后的13G表,表明其精密科学公司股权发生了变化。报告显示,摩根大通现在拥有精密科学公司7521686股普通股,占该公司普通股总数的4.0%。这标志着其持股比例下降,因为报告表明,摩根大通已不再是该证券种类中五成以上的法定所有人。这些股份由各种摩根大通实体持有,包括特拉华州摩根大通信托公司和摩根大通证券有限责任公司等。报告声称这些股份是以业务常规方式获得并持有的,而非意图改变或影响精密科学公司的控制权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息